FDA Investigator Jean Lhu Primmer
Jean Lhu Primmer has conducted inspections on 3 sites in 1 countries as of 13 Dec 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
3
Last Inspection Date:
13 Dec 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Jean Lhu Primmer:
Alan L Truong,
Anissa M Cheung,
Ann Marie Montemurro,
Ann Marie Schofield,
Anthony F Lorenzo,
Brentley S Collins,
Bruce D Meade,
Burnell M Henry,
CDR Cecily Jones,
CDR Donald Ertel,
CDR Jeremy L Wally, PhD,
Christian D Lynch (CDL),
Christine A Harman, PhD,
Cynthia Jim, CSO,
Cynthia L Kelley,
David E Bailey,
Deborah M Trout,
Destry M Sillivan,
Gene D Arcy,
Haruhiko Murata,
Holly Brevig,
Jacqueline Mdiaz Albertini,
Jennifer L Bridgewater,
Joan Johnson,
Julie D Bringger,
LCDR Debra Emerson,
Lewis K Antwi,
Linda Thai,
Lisa P Oakes,
Marsha W Major,
Michael J Vardon,
Michele L Forster, PhD,
Mihaly S Ligmond,
Myra K Casey,
Omotunde O Osunsanmi,
Pankaj H Amin,
Patsy J Domingo,
Paul W Keller,
Paula A Trost,
Penny H Mccarver,
Prabhu P Raju,
Priscilla M Pastrana,
Randa Melhem, PhD,
Richard H Penta,
Robert D Tollefsen,
Rose Ashley,
Shafiq S Ahadi,
Simone E Pitts,
Steven A Rubin,
Steven C Derrick,
Susan M Jackson,
Unnee Ranjan,
William D Tingley,
Xianghong Jing (Emily), PhD,
Xiao Wang
Jean Lhu Primmer's Documents
Publish Date | Document Type | Title |
---|---|---|
December, 2017 | EIR | Emergent Biodefense Operations Lansing LLC - EIR, 2017-12-21 |
December, 2017 | FDA 483 | Emergent Biodefense Operations Lansing LLC - Form 483, 2017-12-21 |
June, 2018 | FDA 483 | Seqirus Inc - Form 483, 2018-06-18 |
September, 2018 | EIR | Emergent Biodefense Operations Lansing LLC - EIR, 2018-09-27 |
September, 2018 | FDA 483 | Emergent Biodefense Operations Lansing LLC - Form 483, 2018-09-27 |
December, 2017 | FDA 483 Response | Emergent Biodefense Operations Lansing LLC - Form 483R, 2018-01-16 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more